Product Recalls in Montana

Product recalls affecting Montana — including food, drugs, consumer products, medical devices, and vehicles distributed to Montana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,524 recalls have been distributed to Montana in the last 12 months.

48,326 total recalls
2,524 in last 12 months

Showing 1032110340 of 13,407 recalls

DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix ST9A (30 mg/2 mg/80 mcg) Injectable Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Quad-Mix 1 Injectable Recalled by The Compounding Pharmacy of America Due to...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 Injectable Recalled by The...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: HCG 3 Recalled by The Compounding Pharmacy of America Due to Lack of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Lipo-DEN III Injection Recalled by The Compounding Pharmacy of America Due...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Fentanyl 15 Recalled by The Compounding Pharmacy of America Due to Lack of...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 50 mg/ml + Clonidine 500 mcg/ml +Bupivacaine 2.5 mg/ml Solution...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Tri-Mix (30/1/10) Injectable Recalled by The Compounding Pharmacy of America...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Estradiol Valerate 40 mg/ml Injectable Recalled by The Compounding Pharmacy...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Morphine 25 mg/ml + Baclofen 100 mcg/ml Solution Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Testosterone 200 mg Anastrazole 1 mg Pellet Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 2, 2015· The Compounding Pharmacy of America

Recalled Item: Magnesium Chloride 200 mg/ml (20%) Injection Recalled by The Compounding...

The Issue: Lack of Assurance of Sterility; FDA inspection identified GMP violations...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Azithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Famotidine tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Lisinopril tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Amlodipine besylate tablets Recalled by American Health Packaging Due to...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Clarithromycin tablets Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJune 1, 2015· American Health Packaging

Recalled Item: Zonisamide capsules Recalled by American Health Packaging Due to CGMP...

The Issue: CGMP Deviations: Firm did not adequately investigate customer complaints.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund